Related Experiment Videos
Growth factors and other targets for rational application as intervention agents
J L Mulshine1, M Birrer, A M Treston
1Biomarkers and Prevention Research Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Advances in Experimental Medicine and Biology
|January 1, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Late first-trimester ultrasound findings can alter management after high-risk NIPT result.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2023
Influence of fibroids on cell-free DNA screening accuracy.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2021
Farnesoid X receptor - a molecular predictor of weight loss after vertical sleeve gastrectomy?
Obesity science & practice·2019
Nucleoskeletal Proteins in Early Embryogenesis.
Advances in experimental medicine and biology·2026
Nuclear Dynamics and Its Timing Regulation Revealed by Live-Cell Imaging.
Advances in experimental medicine and biology·2026
Histone Modifications in Mammalian Early Embryos.
Advances in experimental medicine and biology·2026
Oocyte Kinetochores at the Nexus of Meiotic Drive and Segregation Fidelity.
Advances in experimental medicine and biology·2026
Asymmetric Chromosome Establishment and Segregation During Germline Stem Cell Division.
Advances in experimental medicine and biology·2026
Non-random Sister Chromatid Segregation Mediated by Ribosomal DNA in Drosophila Male Germline Stem Cells.
Advances in experimental medicine and biology·2026
Benzophenone Derivatives as a New Class of Anti-Infectives Against Acanthamoeba spp.
Archiv der Pharmazie·2026
Novel 1H-Indole-3-carboxamide Derivatives as CDK4 Inhibitors for Treating Cancer.
ACS medicinal chemistry letters·2026
Novel Heterocyclic Compounds for Treating HIV Infection.
ACS medicinal chemistry letters·2026
Novel 6,5-Bicyclic Compounds as 5‑HT2A Receptor Agonists for Treating Depression, Anxiety, Substance Abuse, and Headaches.
ACS medicinal chemistry letters·2026